Carcinoembryonic Antigen (CEA) is a tumor marker in lung cancer.

Carcinoembryonic Antigen (CEA) as tumor marker in lung cancer. The use of CEA as a prognostic and predictive marker. CEA is a glycoprotein involved in cell adhesion, and is normally produced during fetal development but the production stops before birth. CEA is a glycosyl phosphatidyl inositol (GPI)-cell surface anchored glycoprotein whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells^[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

965.08

C₄₃H₆₈N₁₀O₁₅

168635-85-6

Tyr-Leu-Ser-Gly-Ala-Asn-Leu-Asn-Leu

YLSGANLNL

癌胚抗原

Room temperature in continental US; may vary elsewhere.

Protect from light

*In solvent : -80deg;C, 6 months; -20deg;C, 1 month (protect from light)

H₂O : 12.5 mg/mL (12.95 mM; Need ultrasonic)

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

• [1]. Grunnet M, et al. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012 May;76(2):138-43.